During the same timeframe during which Ozempic utilization increased by 75%, Trulicity utilization increased only 25%.3 Making a coverage change to a less utilized GLP-1 can rapidly decrease utilization for health plans that are facing unsustainable increases in GLP-1 usage, while preserving options for members who need GLP-1s to remain healthy
400 A followup study with the same cohort showed differences across Asian American subgroups, but all subgroups studied had lower dementia incidence than the White population
Future treatments in hypertension: can we meet the unmet needs of patients
The injection is given into the fatty subcutaneous tissue (often in the abdomen, thigh, or upper arm)
Safer alternatives to grey market tirzepatide For people who cannot afford brand-name tirzepatide, safer options exist
Peptide therapy is being studied as a potential supportive intervention that may influence biological pathways involved in ASD